Annual EBITDA
-$9.97 M
-$28.18 M-154.72%
01 December 2023
Summary:
Opus Genetics annual earnings before interest, taxes, depreciation & amortization is currently -$9.97 million, with the most recent change of -$28.18 million (-154.72%) on 01 December 2023. During the last 3 years, it has risen by +$7.80 million (+43.89%).IRD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$7.53 M
+$802.00 K+9.63%
01 September 2024
Summary:
Opus Genetics quarterly earnings before interest, taxes, depreciation & amortization is currently -$7.53 million, with the most recent change of +$802.00 thousand (+9.63%) on 01 September 2024. Over the past year, it has dropped by -$14.43 million (-209.01%).IRD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$29.68 M
-$14.43 M-94.60%
01 September 2024
Summary:
Opus Genetics TTM earnings before interest, taxes, depreciation & amortization is currently -$29.68 million, with the most recent change of -$14.43 million (-94.60%) on 01 September 2024. Over the past year, it has dropped by -$59.33 million (-200.14%).IRD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IRD EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -154.7% | -209.0% | -200.1% |
| 3 y3 years | +43.9% | -78.0% | +53.4% |
| 5 y5 years | - | - | - |
IRD EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -154.7% | -122.0% | -200.1% |
Opus Genetics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.53 M(-9.6%) | -$29.68 M(+94.6%) |
| June 2024 | - | -$8.33 M(+8.0%) | -$15.25 M(+23.9%) |
| Mar 2024 | - | -$7.71 M(+25.9%) | -$12.31 M(+14.7%) |
| Dec 2023 | -$9.97 M(-154.7%) | -$6.12 M(-188.7%) | -$10.74 M(-136.2%) |
| Sept 2023 | - | $6.90 M(-228.1%) | $29.64 M(+62.8%) |
| June 2023 | - | -$5.39 M(-12.1%) | $18.21 M(-2.5%) |
| Mar 2023 | - | -$6.13 M(-117.9%) | $18.68 M(+2.5%) |
| Dec 2022 | $18.22 M | $34.26 M(-856.2%) | $18.22 M(-181.5%) |
| Sept 2022 | - | -$4.53 M(-8.0%) | -$22.35 M(+1.4%) |
| June 2022 | - | -$4.92 M(-25.3%) | -$22.05 M(-9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$6.59 M(+4.4%) | -$24.26 M(-57.2%) |
| Dec 2021 | -$56.69 M(+219.1%) | -$6.31 M(+49.2%) | -$56.69 M(-10.9%) |
| Sept 2021 | - | -$4.23 M(-40.7%) | -$63.63 M(+5.2%) |
| June 2021 | - | -$7.13 M(-81.7%) | -$60.47 M(+11.5%) |
| Mar 2021 | - | -$39.01 M(+194.3%) | -$54.25 M(+205.4%) |
| Dec 2020 | -$17.77 M(+273.4%) | -$13.25 M(+1141.0%) | -$17.77 M(+293.8%) |
| Sept 2020 | - | -$1.07 M(+16.8%) | -$4.51 M(+31.0%) |
| June 2020 | - | -$914.00 K(-63.9%) | -$3.44 M(+36.1%) |
| Mar 2020 | - | -$2.53 M | -$2.53 M |
| Dec 2019 | -$4.76 M | - | - |
FAQ
- What is Opus Genetics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Opus Genetics?
- What is Opus Genetics annual EBITDA year-on-year change?
- What is Opus Genetics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Opus Genetics?
- What is Opus Genetics quarterly EBITDA year-on-year change?
- What is Opus Genetics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Opus Genetics?
- What is Opus Genetics TTM EBITDA year-on-year change?
What is Opus Genetics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of IRD is -$9.97 M
What is the all time high annual EBITDA for Opus Genetics?
Opus Genetics all-time high annual earnings before interest, taxes, depreciation & amortization is $18.22 M
What is Opus Genetics annual EBITDA year-on-year change?
Over the past year, IRD annual earnings before interest, taxes, depreciation & amortization has changed by -$28.18 M (-154.72%)
What is Opus Genetics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of IRD is -$7.53 M
What is the all time high quarterly EBITDA for Opus Genetics?
Opus Genetics all-time high quarterly earnings before interest, taxes, depreciation & amortization is $34.26 M
What is Opus Genetics quarterly EBITDA year-on-year change?
Over the past year, IRD quarterly earnings before interest, taxes, depreciation & amortization has changed by -$14.43 M (-209.01%)
What is Opus Genetics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of IRD is -$29.68 M
What is the all time high TTM EBITDA for Opus Genetics?
Opus Genetics all-time high TTM earnings before interest, taxes, depreciation & amortization is $29.64 M
What is Opus Genetics TTM EBITDA year-on-year change?
Over the past year, IRD TTM earnings before interest, taxes, depreciation & amortization has changed by -$59.33 M (-200.14%)